Exogenous Glucose–Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes

OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP), unlike glucagon-like peptide (GLP)-1, lacks glucose-lowering properties in patients with type 2 diabetes. We designed this study to elucidate the underlying pathophysiology. RESEARCH DESIGN AND METHODS: Twenty-two insulin-naïve subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Chia, Chee W., Carlson, Olga D., Kim, Wook, Shin, Yu-Kyong, Charles, Cornelia P., Kim, Hee Seung, Melvin, Denise L., Egan, Josephine M.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682676/
https://www.ncbi.nlm.nih.gov/pubmed/19276444
http://dx.doi.org/10.2337/db08-0958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682676/
https://www.ncbi.nlm.nih.gov/pubmed/19276444
http://dx.doi.org/10.2337/db08-0958

Ejemplares similares